Cargando…

Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology

In order to study estrogen-driven microenvironment associated with type 1 endometrial carcinoma, we evaluated estrogen receptors (ERs), aromatase, and cyclooxygenase II (COX2) molecular and immunohistochemical profiles with correlation to clinicopathological features. We investigated aromatase, ERα,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jarzabek, Katarzyna, Koda, Mariusz, Walentowicz-Sadlecka, Malgorzata, Grabiec, Marek, Laudanski, Piotr, Wolczynski, Slawomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858613/ https://www.ncbi.nlm.nih.gov/pubmed/23873111 http://dx.doi.org/10.1007/s13277-013-0991-9

Ejemplares similares

Why do patients decline amniocentesis? Analysis of factors influencing the decision to refuse invasive prenatal testing
por: Sadlecki, Pawel, et al.
Publicado: (2018)

The Preoperative Maximum Standardized Uptake Value Measured by 18F-FDG PET/CT as an Independent Prognostic Factor of Overall Survival in Endometrial Cancer Patients
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2014)

Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus
por: Sadlecki, Pawel, et al.
Publicado: (2016)

Broad ligament pregnancy – A rare and challenging diagnosis
por: Sadłecki, Paweł, et al.
Publicado: (2021)

The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients
por: Sadlecki, Pawel, et al.
Publicado: (2014)

Stromal Derived Factor-1 (SDF-1) and Its Receptors CXCR4 and CXCR7 in Endometrial Cancer Patients
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2014)

Human amniotic fluid as a source of stem cells
por: Walentowicz, Pawel, et al.
Publicado: (2022)

Serum 25(OH) Vitamin D Levels in Polish Women during Pregnancies Complicated by Hypertensive Disorders and Gestational Diabetes
por: Domaracki, Piotr, et al.
Publicado: (2016)

Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer
por: Walentowicz, Pawel, et al.
Publicado: (2013)

Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients
por: Walentowicz, Pawel, et al.
Publicado: (2014)

Gestational Diabetes Mellitus Worsens the Profile of Cardiometabolic Risk Markers and Decrease Indexes of Beta-Cell Function Independently of Insulin Resistance in Nondiabetic Women with a Parental History of Type 2 Diabetes
por: Sokup, Alina, et al.
Publicado: (2014)

Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM)
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2019)

Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers
por: Sadłecki, Paweł, et al.
Publicado: (2019)

Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer
por: Sadłecki, Paweł, et al.
Publicado: (2020)

Altered Peroxisome-Proliferator Activated Receptors Expression in Human Endometrial Cancer
por: Knapp, Paweł, et al.
Publicado: (2012)

Human Adipose-Derived and Amniotic Fluid-Derived Stem Cells: A Preliminary In Vitro Study Comparing Myogenic Differentiation Capability
por: Bajek, Anna, et al.
Publicado: (2018)

Prenatal diagnosis of fetal defects and its implications on the delivery mode
por: Sadlecki, Pawel, et al.
Publicado: (2023)

The DAX1 mutation in a patient with hypogonadotropic hypogonadism and adrenal hypoplasia congenita causes functional disruption of induction of spermatogenesis
por: Ponikwicka-Tyszko, Donata, et al.
Publicado: (2012)

ER and COX2 expression in endometrial hyperplasia processes
por: Tsyndrenko, Nataliia, et al.
Publicado: (2023)

Bilateral aggressive malignant granulosa cell tumour with essentially different immunophenotypes in primary and metastatic lesions comprising predominantly sarcomatoid and fibrothecomatous patterns – looking for prognostic markers: a case report
por: Jozwicki, Wojciech, et al.
Publicado: (2011)

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome
por: Zbucka-Kretowska, Monika, et al.
Publicado: (2017)

Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome
por: Czeczuga-Semeniuk, Ewa, et al.
Publicado: (2014)

Maternal Plasma and Amniotic Fluid Sphingolipids Profiling in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2015)

Maternal Plasma and Amniotic Fluid Chemokines Screening in Fetal Down Syndrome
por: Laudanski, Piotr, et al.
Publicado: (2014)

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2016)

The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer
por: Hojnik, Marko, et al.
Publicado: (2023)

Effect of a hormone-releasing intrauterine system (Mirena(®)) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection
por: Maia, Hugo, et al.
Publicado: (2012)

Potential use of COX-2–aromatase inhibitor combinations in breast cancer
por: Bundred, N J, et al.
Publicado: (2005)

Extracellular Vesicles Inhibit Proliferation and Invasion of Ovarian Endometrial Stromal Cells and Their Expression of SF-1, ERβ, and Aromatase
por: Wang, XiaoQing, et al.
Publicado: (2021)

The Aromatase–Estrogen System in the Testes of Non-Mammalian Vertebrates
por: Rosati, Luigi, et al.
Publicado: (2021)

Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy
por: Sztachelska, Maria, et al.
Publicado: (2022)

Aromatase Inhibitors as Adjuvant Treatment for ER/PgR Positive Stage I Endometrial Carcinoma: A Retrospective Cohort Study
por: Paleari, Laura, et al.
Publicado: (2020)

Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects
por: Crider, Amanda, et al.
Publicado: (2014)

Aromatase expression and role of estrogens in male gonad : a review
por: Carreau, Serge, et al.
Publicado: (2003)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

Aromatase cytochrome P450 gene expression in endometrial carcinoma.
por: Sasano, H., et al.
Publicado: (1996)

Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice
por: Van Sinderen, Michelle L., et al.
Publicado: (2015)

Molecular Basis for Endocrine Disruption by Pesticides Targeting Aromatase and Estrogen Receptor
por: Zhang, Chao, et al.
Publicado: (2020)

Estrogen disorders: Interpreting the abnormal regulation of aromatase in granulosa cells (Review)
por: Liu, Ting, et al.
Publicado: (2021)

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_68mkqa64pu353a8dhq07lfnkk8